Loading insider details...
Beta
Latest Form 4 (Feb 17, 2026): Exercise/Conversion of 1,807 SVRA shares, $3.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 17, 2026 | Savara Inc (SVRA) | Exercise/Conversion | 1,807 | $3.2K |
| Dec 11, 2025 | Savara Inc (SVRA) | Grant/Award | 40,000 | n/a |
| Jun 2, 2025 | Savara Inc (SVRA) | Purchase | 10,000 | $20.8K |
| Dec 16, 2024 | Savara Inc (SVRA) | Grant/Award | 40,000 | n/a |
| Nov 20, 2024 | Savara Inc (SVRA) | Purchase | 20,000 | $59.1K |
| Jun 7, 2024 | LUMOS PHARMA, INC. | Grant/Award | 3,328 | n/a |
| Dec 15, 2023 | Savara Inc (SVRA) | Grant/Award | 22,500 | n/a |
| Dec 15, 2022 | Savara Inc (SVRA) | Grant/Award | 40,000 | n/a |
| Dec 14, 2021 | Savara Inc (SVRA) | Grant/Award | 40,000 | n/a |
| Mar 15, 2021 | Savara Inc (SVRA) | Purchase | 68,965 | $100.0K |